U.K.-based biotech Alchemab on Tuesday announced a licensing agreement with Eli Lilly (NYSE:LLY) to jointly develop ATLX-1282 ...

Ford Motor was the latest to suspend its annual outlook on Monday, joining a host of companies that shelved their forecasts ...

The president signed an executive order to promote domestic pharma production Monday, and said that news on drug tariffs will ...

LLY is bullish in weekly sequence from all time low. It favors rally in (V) after double correction ended at $677.09 low in ...

Lilly plans to break ground Tuesday afternoon on its $4.5 billion Lilly Medicine Foundry in Lebanon. Lilly Chair and CEO Dave ...